Clinical Topics & News
Clinical Topics & News
Interview with Clyde E. Markowitz, MD on switching therapies during MS treatment
News
FDA approves diroximel fumarate for relapsing MS
The oral drug, marketed as Vumerity, converts to the same active metabolite as dimethyl fumarate.
Clinical Topics & News
Interview with Andrew Solomon, MD, on diagnosing multiple sclerosis
Clinical Topics & News
Interview with Andrew Pachner, MD, about the molecular processes of multiple sclerosis
Literature Review
Vaccination is not associated with increased risk of MS
Data indicate an association between vaccination and lower likelihood of incident MS, but do not support conclusions about whether vaccination has...
News
Obesity tied to relapse in young patients with multiple sclerosis
Weight loss or BMI-based dosing might improve treatment response.
Clinical Topics & News
Interview with Mary Alissa Willis, MD, on MS and Mental Health
Clinical Topics & News
Interview with Brenda L. Banwell, MD, on Pediatric-onset MS
News
BTK inhibitor reduces MS enhancing lesions
However, neither the 75-mg nor 25-mg dosing regimens significantly reduced Expanded Disability Status Scale scores, compared with placebo.